Hannah Sore

Hannah Sore is the CEO and Co-Founder of PharmEnable. Hannah has over 10 years of experience in scientific consulting, bridging the gap between science and business.

Previously, they were the Founder and Director of HFS Scientific, a scientific consulting firm that works with healthcare and scientific companies to develop their growth strategies.

Before that, they worked as a Healthcare Consultant at Frost & Sullivan and as a Research Manager at the University of Cambridge, where their research was focused on Infectious Diseases and Oncology.

Hannah is committed to making a difference in the healthcare industry and is constantly looking for new ways to improve the quality of care for patients.

Hannah Sore first completed their MSci in Chemistry at Durham University. Hannah then went on to complete their PhD in Organic Chemistry at the University of Cambridge.

David Vidal - Director of Molecular Informatics & AI, James Dale - Director of Drug Discovery, and Natalia Mateu - Co-Founder & CSO report to Hannah Sore.